Thursday, May 23, 2024
Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.
Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Divestiture strategy coming to fruition. During 2024, the company made significant progress in an organizational transformation long in the making. After its spinoff from Xerox in 2017, the company had plans to become a more streamlined business. But, it is the current management team that has successfully executed several key divestitures. In our view, the company is on track to become more efficient, with a healthier balance sheet, and with attractive revenue and cash flow growth.
Meeting proceeds target. On May 2, 2024, the company announced that is has agreed to sell its Casualty Claims Solutions business (related to workers’ comp) to MedRisk for $240 million in cash. Notably, we believe the company has now announced the bulk of its divestitures and is in line to achieve its goal of $600-$800 million of net divestiture proceeds. On a gross basis, the company is expecting roughly $900 million in proceeds.
Get the Full Report
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
